WO2004081197A3 - Immune response associated proteins - Google Patents
Immune response associated proteins Download PDFInfo
- Publication number
- WO2004081197A3 WO2004081197A3 PCT/US2004/007716 US2004007716W WO2004081197A3 WO 2004081197 A3 WO2004081197 A3 WO 2004081197A3 US 2004007716 W US2004007716 W US 2004007716W WO 2004081197 A3 WO2004081197 A3 WO 2004081197A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- immune response
- associated proteins
- irap
- response associated
- polynucleotides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Applications Claiming Priority (12)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US45445103P | 2003-03-12 | 2003-03-12 | |
US60/454,451 | 2003-03-12 | ||
US45869503P | 2003-03-27 | 2003-03-27 | |
US60/458,695 | 2003-03-27 | ||
US46053003P | 2003-04-04 | 2003-04-04 | |
US60/460,530 | 2003-04-04 | ||
US46923603P | 2003-05-09 | 2003-05-09 | |
US60/469,236 | 2003-05-09 | ||
US48329403P | 2003-06-26 | 2003-06-26 | |
US60/483,294 | 2003-06-26 | ||
US49142003P | 2003-07-30 | 2003-07-30 | |
US60/491,420 | 2003-07-30 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2004081197A2 WO2004081197A2 (en) | 2004-09-23 |
WO2004081197A3 true WO2004081197A3 (en) | 2007-03-29 |
Family
ID=32996648
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2004/007716 WO2004081197A2 (en) | 2003-03-12 | 2004-03-11 | Immune response associated proteins |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2004081197A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0524866D0 (en) * | 2005-12-05 | 2006-01-11 | Univ Aberdeen | Method of tolerisation |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1006183A1 (en) * | 1998-12-03 | 2000-06-07 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Recombinant soluble Fc receptors |
WO2001082774A2 (en) * | 2000-04-21 | 2001-11-08 | Rutgers, The State University Of New Jersey | Methods and compositions for the diagnosis of schizophrenia |
-
2004
- 2004-03-11 WO PCT/US2004/007716 patent/WO2004081197A2/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1006183A1 (en) * | 1998-12-03 | 2000-06-07 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Recombinant soluble Fc receptors |
WO2001082774A2 (en) * | 2000-04-21 | 2001-11-08 | Rutgers, The State University Of New Jersey | Methods and compositions for the diagnosis of schizophrenia |
Also Published As
Publication number | Publication date |
---|---|
WO2004081197A2 (en) | 2004-09-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2004087875A3 (en) | Nucleic acid-associated proteins | |
WO2004048550A3 (en) | Immune response associated proteins | |
WO2002097060A3 (en) | Carbohydrate-associated proteins | |
WO2004044165A3 (en) | Lipid-associated proteins | |
WO2003068943A3 (en) | Secreted proteins | |
WO2001085942A3 (en) | Cytoskeleton-associated proteins | |
WO2003062391A3 (en) | Structural and cytoskeleton-associated proteins | |
WO2003076586A3 (en) | Nucleic acid-associated proteins | |
WO2004100774A3 (en) | Receptors and membrane-associated proteins | |
WO2002053719A3 (en) | Cytoskeleton-associated proteins | |
WO2003025542A3 (en) | Immune response associated proteins | |
WO2002066646A3 (en) | Neurotransmission-associated proteins | |
WO2004003162A3 (en) | Enzymes | |
WO2003087300A3 (en) | Secreted proteins | |
WO2004020593A3 (en) | Immune response associated proteins | |
WO2003074726A3 (en) | Immune response associated proteins | |
WO2003072729A3 (en) | Enzymes | |
WO2004094589A3 (en) | Secreted proteins | |
WO2004022705A3 (en) | Neurotransmission-associated proteins | |
WO2003083082A3 (en) | Enzymes | |
WO2003093439A3 (en) | Enzymes | |
WO2004081197A3 (en) | Immune response associated proteins | |
WO2000052161A3 (en) | Leukocyte- and blood-associated proteins | |
WO2004111202A3 (en) | Neurotransmission-association proteins | |
WO2004007527A3 (en) | Secreted proteins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase |